Zebrafish as a Model for the Study of Human Cancer

Methods in Cell Biology

Volumn 105, Issue , 2011, Pages 309-337

  Etchin, Julia ^a   Kanki, John P ^a   Look, A Thomas ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Intravasation; Malignant; Melanoma; Mutagenesis; Rhabdomyosarcoma; Xenotransplantation

Indexed keywords

EID: 80053196613     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381320-6.00013-8     Document Type: Chapter

References (96)

1. Alex D., Lam I.K., Lin Z., Lee S.M. Indirubin shows anti-angiogenic activity in an in vivo zebrafish model and an in vitro HUVEC model. J. Ethnopharmacol. 2010, 131:242-247.
2. Amatruda J.F., Patton E.E. Genetic models of cancer in zebrafish. Int. Rev. Cell Mol. Biol. 2008, 271:1-34.
3. Amsterdam A., Burgess S., Golling G., Chen W., Sun Z., Townsend K., Farrington S., Haldi M., Hopkins N. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 1999, 13:2713-2724.
4. Amsterdam A., Hopkins N. Retrovirus-mediated insertional mutagenesis in zebrafish. Methods Cell Biol. 1999, 60:87-98.
5. Amsterdam A., Lai K., Komisarczuk A.Z., Becker T.S., Bronson R.T., Hopkins N., Lees J.A. Zebrafish Hagoromo mutants up-regulate fgf8 postembryonically and develop neuroblastoma. Mol. Cancer Res. 2009, 7:841-850.
6. Amsterdam A., Sadler K.C., Lai K., Farrington S., Bronson R.T., Lees J.A., Hopkins N. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2004, 2:E139.
7. Anelli V., Santoriello C., Distel M., Koster R.W., Ciccarelli F.D., Mione M. Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation. Zebrafish 2009, 6:417-424.
8. Balciunas D., Ekker S.C. Trapping fish genes with transposons. Zebrafish 2005, 1:335-341.
9. Berghmans S., Murphey R.D., Wienholds E., Neuberg D., Kutok J.L., Fletcher C.D., Morris J.P., Liu T.X., Schulte-Merker S., Kanki J.P., et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:407-412.
10. Bienz M., Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000, 103:311-320.
11. Blackburn J.S., Langenau D.M. aMAZe-ing tools for mosaic analysis in zebrafish. Nat. Methods 2010, 7:188-190.
12. Bowman T.V., Zon L.I. Swimming into the future of drug discovery: in vivo chemical screens in zebrafish. ACS Chem. Biol. 2010, 5:159-161.
13. Chen J., Jette C., Kanki J.P., Aster J.C., Look A.T., Griffin J.D. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 2007, 21:462-471.
14. Collins R.T., Linker C., Lewis J. MAZe: a tool for mosaic analysis of gene function in zebrafish. Nat. Methods 2010, 7:219-223.
15. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
16. Dayyani F., Wang J., Yeh J.R., Ahn E.Y., Tobey E., Zhang D.E., Bernstein I.D., Peterson R.T., Sweetser D.A. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood 2008, 111:4338-4347.
17. Dong M., Fu Y.F., Du T.T., Jing C.B., Fu C.T., Chen Y., Jin Y., Deng M., Liu T.X. Heritable and lineage-specific gene knockdown in zebrafish embryo. PLoS One 2009, 4:e6125.
18. Dovey M., White R.M., Zon L.I. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish 2009, 6:397-404.
19. Doyon Y., McCammon J.M., Miller J.C., Faraji F., Ngo C., Katibah G.E., Amora R., Hocking T.D., Zhang L., Rebar E.J., et al. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat. Biotechnol 2008, 26:702-708.
20. Eisinger A.L., Nadauld L.D., Shelton D.N., Peterson P.W., Phelps R.A., Chidester S., Stafforini D.M., Prescott S.M., Jones D.A. The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. J. Biol. Chem. 2006, 281:20474-20482.
21. Faucherre A., Taylor G.S., Overvoorde J., Dixon J.E., Hertog J. Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development. Oncogene 2008, 27:1079-1086.
22. Feitsma H., Cuppen E. Zebrafish as a cancer model. Mol. Cancer Res. 2008, 6:685-694.
23. Feitsma H., Kuiper R.V., Korving J., Nijman I.J., Cuppen E. Zebrafish with mutations in mismatch repair genes develop neurofibromas and other tumors. Cancer Res. 2008, 68:5059-5066.
24. Feng H., Langenau D.M., Madge J.A., Quinkertz A., Gutierrez A., Neuberg D.S., Kanki J.P., Look A.T. Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish. Br. J. Haematol. 2007, 138:169-175.
25. Feng H., Stachura D.L., White R.M., Gutierrez A., Zhang L., Sanda T., Jette C.A., Testa J.R., Neuberg D.S., Langenau D.M., et al. T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell 2010, 18:353-366.
26. Frazer J.K., Meeker N.D., Rudner L., Bradley D.F., Smith A.C., Demarest B., Joshi D., Locke E.E., Hutchinson S.A., Tripp S., et al. Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia 2009, 23:1825-1835.
27. Grabher C., Wittbrodt J. Recent advances in meganuclease-and transposon-mediated transgenesis of medaka and zebrafish. Methods Mol. Biol. 2008, 461:521-539.
28. Haldi M., Ton C., Seng W.L., McGrath P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 2006, 9:139-151.
29. Hao J., Ho J.N., Lewis J.A., Karim K.A., Daniels R.N., Gentry P.R., Hopkins C.R., Lindsley C.W., Hong C.C. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem. Biol. 2010, 5:245-253.
30. Haramis A.P., Hurlstone A., van der Velden Y., Begthel H., van den Born M., Offerhaus G.J., Clevers H.C. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep. 2006, 7:444-449.
31. He Z.H., Ge W., Yue G.G., Lau C.B., He M.F., But P.P. Anti-angiogenic effects of the fruit of Alpinia oxyphylla. J. Ethnopharmacol 2010, 132(2):443-449.
32. Hruban R.H., van Mansfeld A.D., Offerhaus G.J., van Weering D.H., Allison D.C., Goodman S.N., Kensler T.W., Bose K.K., Cameron J.L., Bos J.L. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am. J. Pathol. 1993, 143:545-554.
33. Hruban R.H., Wilentz R.E., Kern S.E. Genetic progression in the pancreatic ducts. Am. J. Pathol. 2000, 156:1821-1825.
34. Hurlstone A.F., Haramis A.P., Wienholds E., Begthel H., Korving J., Van Eeden F., Cuppen E., Zivkovic D., Plasterk R.H., Clevers H. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 2003, 425:633-637.
35. Ignatius M.S., Langenau D.M. Zebrafish as a model for cancer self-renewal. Zebrafish 2009, 6:377-387.
36. Isogai S., Lawson N.D., Torrealday S., Horiguchi M., Weinstein B.M. Angiogenic network formation in the developing vertebrate trunk. Development 2003, 130:5281-5290.
37. Kalev-Zylinska M.L., Horsfield J.A., Flores M.V., Postlethwait J.H., Vitas M.R., Baas A.M., Crosier P.S., Crosier K.E. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development 2002, 129:2015-2030.
38. Kwan K.M., Fujimoto E., Grabher C., Mangum B.D., Hardy M.E., Campbell D.S., Parant J.M., Yost H.J., Kanki J.P., Chien C.B. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev. Dyn. 2007, 236:3088-3099.
39. Lam S.H., Wu Y.L., Vega V.B., Miller L.D., Spitsbergen J., Tong Y., Zhan H., Govindarajan K.R., Lee S., Mathavan S., et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat. Biotechnol. 2006, 24:73-75.
40. Langenau D.M., Feng H., Berghmans S., Kanki J.P., Kutok J.L., Look A.T. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:6068-6073.
41. Langenau D.M., Keefe M.D., Storer N.Y., Guyon J.R., Kutok J.L., Le X., Goessling W., Neuberg D.S., Kunkel L.M., Zon L.I. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev. 2007, 21:1382-1395.
42. Langenau D.M., Keefe M.D., Storer N.Y., Jette C.A., Smith A.C., Ceol C.J., Bourque C., Look A.T., Zon L.I. Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic zebrafish. Oncogene 2008, 27:4242-4248.
43. Langenau D.M., Traver D., Ferrando A.A., Kutok J.L., Aster J.C., Kanki J.P., Lin S., Prochownik E., Trede N.S., Zon L.I., Look A.T. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003, 299:887-890.
44. Lawson N.D., Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 2002, 248:307-318.
45. Le X., Langenau D.M., Keefe M.D., Kutok J.L., Neuberg D.S., Zon L.I. Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:9410-9415.
46. MacInnes A.W., Amsterdam A., Whittaker C.A., Hopkins N., Lees J.A. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10408-10413.
47. Meng X., Noyes M.B., Zhu L.J., Lawson N.D., Wolfe S.A. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat. Biotechnol. 2008, 26:695-701.
48. Merlino G., Khanna C. Fishing for the origins of cancer. Genes Dev. 2007, 21:1275-1279.
49. Michailidou C., Jones M., Walker P., Kamarashev J., Kelly A., Hurlstone A.F. Dissecting the roles of Raf- and PI3K-signalling pathways in melanoma formation and progression in a zebrafish model. Dis. Model Mech 2009, 2:399-411.
50. Mizgireuv I.V., Revskoy S.Y. Transplantable tumor lines generated in clonal zebrafish. Cancer Res. 2006, 66:3120-3125.
51. Motoike T., Loughna S., Perens E., Roman B.L., Liao W., Chau T.C., Richardson C.D., Kawate T., Kuno J., Weinstein B.M., et al. Universal GFP reporter for the study of vascular development. Genesis 2000, 28:75-81.
52. Mullins M.C., Hammerschmidt M., Haffter P., Nusslein-Volhard C. Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr. Biol. 1994, 4:189-202.
53. Murphey R.D., Stern H.M., Straub C.T., Zon L.I. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem. Biol. Drug Des. 2006, 68:213-219.
54. Murphy E.A., Shields D.J., Stoletov K., Dneprovskaia E., McElroy M., Greenberg J.I., Lindquist J., Acevedo L.M., Anand S., Majeti B.K., et al. Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4299-4304.
55. Neumann J.C., Dovey J.S., Chandler G.L., Carbajal L., Amatruda J.F. Identification of a heritable model of testicular germ cell tumor in the zebrafish. Zebrafish 2009, 6:319-327.
56. Nicoli S., Ribatti D., Cotelli F., Presta M. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res. 2007, 67:2927-2931.
57. Onnebo S.M., Condron M.M., McPhee D.O., Lieschke G.J., Ward A.C. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp. Hematol. 2005, 33:182-188.
58. Papp T., Pemsel H., Zimmermann R., Bastrop R., Weiss D.G., Schiffmann D. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet. 1999, 36:610-614.
59. Parant J.M., George S.A., Holden J.A., Yost H.J. Genetic modeling of Li-Fraumeni syndrome in zebrafish. Dis. Model Mech. 2010, 3:45-56.
60. Park S.W., Davison J.M., Rhee J., Hruban R.H., Maitra A., Leach S.D. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 2008, 134:2080-2090.
61. Park D.M., Zhuang Z., Chen L., Szerlip N., Maric I., Li J., Sohn T., Kim S.H., Lubensky I.A., Vortmeyer A.O., et al. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007, 4:e60.
62. Patton E.E., Mitchell D.L., Nairn R.S. Genetic and environmental melanoma models in fish. Pigment Cell Melanoma Res. 2010, 23:314-337.
63. Patton E.E., Widlund H.R., Kutok J.L., Kopani K.R., Amatruda J.F., Murphey R.D., Berghmans S., Mayhall E.A., Traver D., Fletcher C.D., et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 2005, 15:249-254.
64. Pavelic K., Hrascan R., Kapitanovic S., Karapandza N., Vranes Z., Belicza M., Kruslin B., Cabrijan T. Multiple genetic alterations in malignant metastatic insulinomas. J. Pathol. 1995, 177:395-400.
65. Pavelic K., Hrascan R., Kapitanovic S., Vranes Z., Cabrijan T., Spaventi S., Korsic M., Krizanac S., Li Y.Q., Stambrook P., et al. Molecular genetics of malignant insulinoma. Anticancer Res. 1996, 16:1707-1717.
66. Phelps R.A., Chidester S., Dehghanizadeh S., Phelps J., Sandoval I.T., Rai K., Broadbent T., Sarkar S., Burt R.W., Jones D.A. A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 2009, 137:623-634.
67. Raetz E.A., Perkins S.L., Bhojwani D., Smock K., Philip M., Carroll W.L., Min D.J. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr. Blood Cancer 2006, 47:130-140.
68. Rai K., Sarkar S., Broadbent T.J., Voas M., Grossmann K.F., Nadauld L.D., Dehghanizadeh S., Hagos F.T., Li Y., Toth R.K., et al. DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. Cell 2010, 142:930-942.
69. Rhodes J., Amsterdam A., Sanda T., Moreau L.A., McKenna K., Heinrichs S., Ganem N.J., Ho K.W., Neuberg D.S., Johnston A., et al. Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppression. Mol. Cell. Biol. 2009, 29:5911-5922.
70. Sabaawy H.E., Azuma M., Embree L.J., Tsai H.J., Starost M.F., Hickstein D.D. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15166-15171.
71. Sahai E. Illuminating the metastatic process. Nat. Rev. Cancer 2007, 7:737-749.
72. Shepard J.L., Amatruda J.F., Stern H.M., Subramanian A., Finkelstein D., Ziai J., Finley K.R., Pfaff K.L., Hersey C., Zhou Y., et al. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13194-13199.
73. Sidi S., Sanda T., Kennedy R.D., Hagen A.T., Jette C.A., Hoffmans R., Pascual J., Imamura S., Kishi S., Amatruda J.F., et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 2008, 133:864-877.
74. Smith A.C., Raimondi A.R., Salthouse C.D., Ignatius M.S., Blackburn J.S., Mizgirev I.V., Storer N.Y., de Jong J.L., Chen A.T., Zhou Y., et al. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Blood 2010, 115:3296-3303.
75. Stern H.M., Murphey R.D., Shepard J.L., Amatruda J.F., Straub C.T., Pfaff K.L., Weber G., Tallarico J.A., King R.W., Zon L.I. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol. 2005, 1:366-370.
76. Stokoe D. Pten. Curr. Biol. 2001, 11:R502.
77. Stoletov K., Kato H., Zardouzian E., Kelber J., Yang J., Shattil S., Klemke R. Visualizing extravasation dynamics of metastatic tumor cells. J. Cell Sci. 2010, 123:2332-2341.
78. Stoletov K., Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene 2008, 27:4509-4520.
79. Stoletov K., Montel V., Lester R.D., Gonias S.L., Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17406-17411.
80. Sun H., Lesche R., Li D.M., Liliental J., Zhang H., Gao J., Gavrilova N., Mueller B., Liu X., Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6199-6204.
81. Suster M.L., Kikuta H., Urasaki A., Asakawa K., Kawakami K. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol. Biol. 2009, 561:41-63.
82. Taylor K.L., Grant N.J., Temperley N.D., Patton E.E. Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads. Cell Commun. Signal. 2010, 8:11.
83. Taylor A.M., Zon L.I. Zebrafish tumor assays: the state of transplantation. Zebrafish 2009, 6:339-346.
84. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernandez-del Castillo C., Yajnik V., et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425:851-856.
85. Topczewska J.M., Postovit L.M., Margaryan N.V., Sam A., Hess A.R., Wheaton W.W., Nickoloff B.J., Topczewski J., Hendrix M.J. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat. Med. 2006, 12:925-932.
86. van Rooijen E., Voest E.E., Logister I., Bussmann J., Korving J., van Eeden F.J., Giles R.H., Schulte-Merker S. von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish. Dis. Model Mech. 2010, 3:343-353.
87. Vlecken D.H., Bagowski C.P. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells. Zebrafish 2009, 6:433-439.
88. Wang C., Tao W., Wang Y., Bikow J., Lu B., Keating A., Verma S., Parker T.G., Han R., Wen X.Y. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. Eur. Urol. 2010, 58:418-426.
89. Wheeler G.N., Brandli A.W. Simple vertebrate models for chemical genetics and drug discovery screens: lessons from zebrafish and Xenopus. Dev. Dyn. 2009, 238:1287-1308.
90. White R.M., Sessa A., Burke C., Bowman T., LeBlanc J., Ceol C., Bourque C., Dovey M., Goessling W., Burns C.E., Zon L.I. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008, 2:183-189.
91. Wienholds E., van Eeden F., Kosters M., Mudde J., Plasterk R.H., Cuppen E. Efficient target-selected mutagenesis in zebrafish. Genome Res. 2003, 13:2700-2707.
92. Yang H.W., Kutok J.L., Lee N.H., Piao H.Y., Fletcher C.D., Kanki J.P., Look A.T. Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res. 2004, 64:7256-7262.
93. Yeh J.R., Munson K.M., Chao Y.L., Peterson Q.P., Macrae C.A., Peterson R.T. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development 2008, 135:401-410.
94. Yeh J.R., Munson K.M., Elagib K.E., Goldfarb A.N., Sweetser D.A., Peterson R.T. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat. Chem. Biol. 2009, 5:236-243.
95. Zhang G., Hoersch S., Amsterdam A., Whittaker C.A., Lees J.A., Hopkins N. Highly aneuploid zebrafish malignant peripheral nerve sheath tumors have genetic alterations similar to human cancers. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16940-16945.
96. Zhuravleva J., Paggetti J., Martin L., Hammann A., Solary E., Bastie J.N., Delva L. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. Br. J. Haematol. 2008, 143:378-382.